T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.06B |
| 2 |
Amphenol
APH
|
+$728M |
| 3 |
Advanced Micro Devices
AMD
|
+$608M |
| 4 |
Zscaler
ZS
|
+$517M |
| 5 |
Northrop Grumman
NOC
|
+$479M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$1B |
| 2 |
Mastercard
MA
|
+$809M |
| 3 |
Visa
V
|
+$621M |
| 4 |
Fortinet
FTNT
|
+$606M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$568M |
Sector Composition
| 1 | Technology | 27.6% |
| 2 | Healthcare | 20.51% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 11.2% |
| 5 | Financials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
LCI Industries
LCII
$2.5B
| $7.26M | ﹤0.01% |
83,050
-225,805
| -73% | -$19.7M |
|
577
Walt Disney
DIS
$213B
| $7.01M | ﹤0.01% |
71,025
+18,525
| +35% | +$1.83M |
|
578
CAVA Group
CAVA
$7.42B
| $6.46M | ﹤0.01% |
74,784
-10,708
| -13% | -$925K |
|
579
Iovance Biotherapeutics
IOVA
$847M
| $6.43M | ﹤0.01% |
1,930,020
-3,904,436
| -67% | -$13M |
|
580
Applied Materials
AMAT
$130B
| $6.26M | ﹤0.01% |
43,115
+40,453
| +1,520% | +$5.87M |
|
581
Commercial Metals
CMC
$6.54B
| $6.25M | ﹤0.01% |
+135,896
| New | +$6.25M |
|
582
Patrick Industries
PATK
$3.74B
| $6.08M | ﹤0.01% |
+71,837
| New | +$6.08M |
|
583
Pacific Biosciences
PACB
$375M
| $5.77M | ﹤0.01% |
4,888,612
-8,232
| -0.2% | -$9.72K |
|
584
Ametek
AME
$42.9B
| $5.7M | ﹤0.01% |
33,126
-30,531
| -48% | -$5.26M |
|
585
Cabaletta Bio
CABA
$150M
| $5.5M | ﹤0.01% |
3,970,026
-103,980
| -3% | -$144K |
|
586
Flywire
FLYW
$1.61B
| $5.18M | ﹤0.01% |
545,601
-348,353
| -39% | -$3.31M |
|
587
Applied Therapeutics
APLT
$63.3M
| $5.08M | ﹤0.01% |
10,380,590
+4,959,670
| +91% | +$2.43M |
|
588
Privia Health
PRVA
$2.86B
| $4.92M | ﹤0.01% |
219,058
-3,555,698
| -94% | -$79.8M |
|
589
Tango Therapeutics
TNGX
$767M
| $4.54M | ﹤0.01% |
3,312,449
-33,102
| -1% | -$45.4K |
|
|
BBOT
590
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$909M
| $4.5M | ﹤0.01% |
397,962
-2,285
| -0.6% | -$25.8K |
|
591
Orion
OEC
$585M
| $4.12M | ﹤0.01% |
318,376
-944,232
| -75% | -$12.2M |
|
592
Lam Research
LRCX
$133B
| $4.1M | ﹤0.01% |
56,397
-90,883
| -62% | -$6.61M |
|
593
Sezzle
SEZL
$3.01B
| $4.01M | ﹤0.01% |
+114,960
| New | +$4.01M |
|
594
Arvinas
ARVN
$585M
| $3.85M | ﹤0.01% |
548,104
-1,660,130
| -75% | -$11.7M |
|
595
Tetra Tech
TTEK
$9.25B
| $3.5M | ﹤0.01% |
119,505
-1,317,099
| -92% | -$38.5M |
|
596
Eagle Materials
EXP
$7.42B
| $3.29M | ﹤0.01% |
14,815
-20,331
| -58% | -$4.51M |
|
597
Jasper Therapeutics
JSPR
$41.3M
| $3.02M | ﹤0.01% |
702,757
+620,592
| +755% | +$2.67M |
|
598
Grid Dynamics Holdings
GDYN
$660M
| $2.97M | ﹤0.01% |
189,962
-508,848
| -73% | -$7.96M |
|
599
Toro Company
TTC
$7.74B
| $2.36M | ﹤0.01% |
32,442
-1,253
| -4% | -$91.2K |
|
|
TLN
600
Talen Energy Corporation Common Stock
TLN
$17.9B
| $2.35M | ﹤0.01% |
11,751
-13,087
| -53% | -$2.61M |
|